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SUMMARY
Background
Antiendomysial (EmA) and antitransglutaminase (anti-tTG) antibodies
are the most specific indirect marker of coeliac disease (CD). It is not
known whether the oral mucosa of patients with CD is able to produce
these antibodies or not.
Aims
To evaluate the ability of the oral mucosa of patients with CD to pro-
duce antibodies in an in vitro culture system.
Patients and methods
Twenty-eight patients with new diagnosis of CD (15 adults and 13 chil-
dren) and 14 adult subjects with other diseases (controls) were studied.
All underwent oral mucosa biopsy and subsequent EmA and anti-tTG
assays on the mucosa culture medium.
Results
Sensitivity and specificity of EmA and anti-tTG assayed in the oral
mucosa culture medium for CD diagnosis were 54% and 100% and 57%
and 100%, respectively. The CD clinical presentation, such as the pres-
ence of oral mucosa lesions, did not influence the results of the EmA
and anti-tTG assays in the oral mucosa culture medium. There was an
association between positivity of antibodies and greater severity of the
oral mucosa lymphocyte infiltration.
Conclusion
This study demonstrates that the oral mucosa contributes to EmA and
anti-tTG production in untreated patients with CD.
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INTRODUCTION
Celiac disease (CD) is one of the most common chronic
diseases among Caucasians, with a frequency in the
general population between 1:85 and 1:300 in both
Europe and the US.1–5 According to current criteria, CD
diagnosis is based on the combination of clinical, histo-
logical and serologic data.6, 7 In fact, it is necessary
to demonstrate intestinal villous atrophy and the
presence of circulating antiendomysial (EmA) and ⁄or
antitransglutaminase (anti-tTG) antibodies on a gluten-
containing diet and the subsequent disappearance of
symptoms on gluten-free diet, although there is evi-
dence that a percentage of patients with CD can have
minimal intestinal histology damage and ⁄or negative
serum EmA and anti-tTG at CD diagnosis.8–11
In any case, an endoscopic approach with intestinal
biopsy for the histological diagnosis is still necessary,12
although this requires an invasive procedure. A site
which could be studied with less invasiveness is the
mouth. In fact, previous reports on the oral mucosa
showed that the challenge performed in treated patients
with CD, either supramucosally with gliadin powder or
by submucosal injection of dissolved gliadin, deter-
mined an inflammatory reaction.13, 14
The aims of this pilot study were to evaluate:
(i) whether the oral mucosa of patients with CD is able
to produce EmA and anti-tTG in an in vitro culture
system or not, (ii) the possible clinical usefulness of
EmA and anti-tTG in vitro production evaluated by
oral mucosa culture.
PATIENTS AND METHODS
Patients with new CD diagnosis observed in three cen-
tres (one for paediatric and two for adult patients),
between June 2004 and May 2005, were randomly
invited to enter the study. Out of a total of 105 new
diagnoses, 51 patients were asked to participate and
28 subjects accepted and were recruited. Of these, 15
were adults (10 F, 5 M, median age 39 years, range
19–73 years) and 13 children (10 F, 3 M, median age
7 years, range 1–16 years). The CD clinical presenta-
tion was typical (malabsorption syndrome) in 14
patients, atypical (absence of intestinal symptoms) in
12 and silent in two (patients identified through
screening programs).7
In all patients, CD diagnosis was based on serum
EmA and anti-tTG positivity associated with evidence
of intestinal villi damage (villous height ⁄ crypt depth
ratio < 3), and in all cases on a subsequent gluten-free
diet clinical symptoms disappeared and EmA and anti-
tTGs became negative.
Furthermore, 14 adult patients (8 F, 6 M, median
age 36.5 years, range 21–70 years) with symptoms
compatible with CD diagnosis but negative for serum
EmA and anti-tTG assays were enrolled. They were
being investigated for the presence of one or more of
the following symptoms: weight loss or failure to
thrive, anaemia, chronic diarrhoea, or abdominal pain.
All underwent oesophago-gastro-duodenoscopy
(OGDS) with duodenal histology examination, oral
mucosa biopsy and EmA and anti-tTG assays in both
the duodenal and oral mucosa culture medium. All
showed normal histology of the intestinal mucosa and
were considered control subjects. In these cases, the
complete diagnostic work-up may also have included
routine haemato-chemical assays, a thyroid study,
serum autoantibodies assay, abdominal ultrasonogra-
phy and ⁄or computed tomography, colonoscopy,
small-intestine barium examination, H2 breath test,
duodenal fluid microbiological evaluation and bone
marrow biopsy.
All the adult patients included in the study were fol-
lowed as out-patients, whereas the children were hos-
pitalized.
The protocol was approved by the Ethics Committee
of the University Hospital of Palermo and informed
consent was obtained from the patients involved in
the study or from the parents in the case of the paedi-
atric patients.
Serology for CD diagnosis
Serum IgA was measured by ELISA to exclude IgA
deficiency. IgA EmAs and anti-tTGs were assayed
using commercial kits as previously described.15
Intestinal and oral biopsies and histology study
Following general anaesthesia (in children) or con-
scious sedation with meperidine ⁄pethidine 1 mg ⁄kg
i.v. and midazolam 0.05–0.1 mg ⁄kg i.v. (in adults),
OGDS were performed with standard paediatric or
adult video-colonoscopes (Olympus or Fujinon or
Pentax, Milan, Italy). Six duodenal biopsy samples
were obtained from each patient. Four samples under-
went routine histology evaluation, and two specimens
were cultured for 72 h at 37 C with a commercial
reagent set (anti-Endomysium-biopsy, Eurospital), as
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described previously.16, 17 One sample was cultured in
the presence of the 31–43 gliadin peptide (0.1 g ⁄L)
and the other without its addition. Culture superna-
tants were collected and stored at )80 C until used.
IgA EmA antibodies in undiluted supernatants were
determined by the same commercial reagent set used
for serum EmA.
IgA anti-tTG antibodies were determined using a
commercial ELISA as recently described.16 In brief,
recombinant human-t TG (h-tTG) antigen diluted in
phosphate-buffered saline was used to coat the wells.
The culture medium was diluted 1:5. The conjugate
was diluted to obtain reliable optical density (OD).
Absorbance was read in a microplate reader at 450 nm.
Anti-tTG values in the supernatants were expressed as
OD. Normal values were taken as <300, representing a
value >2 s.d. above the mean of 200 healthy indivi-
duals. The intra-assay CV for the IgA h-tTG autoanti-
body ELISA on culture medium was 4.2% (n = 20), and
the inter-assay CV was 5.9% (n = 20).
Oral mucosa biopsy specimens were taken at the
same time as the OGDS in children and under local
anaesthesia (xylocain adrenalin) in adults. The speci-
mens were taken in the mouth, at the second molar
tooth region, beneath the occlusal line. Each sample
was divided into four parts: two were fixed to be proc-
essed for histology evaluation and two were cultured
with the procedure described above for the EmA assay
in the duodenal mucosa culture medium. Before cul-
ture, biopsy samples were weighed (minimal weight
required 5 mg ⁄ fragment) and washed.
Previous studies in which IgA EmAs and anti-tTG
antibodies were first assayed on fresh medium and
then 6 months later after storage at )80 C, had
shown that storage did not alter the results obtained,
as EmA and anti-tTG results were identical.16, 17 IgA
EmA and anti-tTG assays on the culture media were
performed by personnel unaware of the clinical and
laboratory data of the patients.
Biopsy specimens of the intestinal mucosa adequate
in size were immediately oriented with a stereomicro-
scope and subsequently embedded in paraffin.15–17 The
slides were stained with haematoxylin and eosin and
graded by conventional histology according to
Oberhuber et al.18
Biopsy specimens of the oral mucosa were embed-
ded in paraffin and the slides stained with haemat-
oxylin and eosin; lamina propria lymphocytes
infiltration was arbitrarily graded as mild when £10
lymphocytes · 5 HPF (magnification 40·) were
counted, and severe when there were >10 lympho-
cytes · 5 HPF.
STATISTICAL ANALYSIS
We followed the STARD checklist for studies on the
diagnostic accuracy of tests.19 The sensitivity, specific-
ity and diagnostic accuracy values of the diagnostic
procedures examined were calculated by standard sta-
tistical methods.20 The Fisher exact test was used to
compare the different sensitivity, specificity and diag-
nostic accuracy values of the assays. The chi-squared
test for trend was calculated to compare the frequency
of CD cases showing mild, moderate or severe intesti-
nal villous atrophy with or without EmA or anti-tTG
positive assays in the culture medium.
RESULTS
None of the patients enrolled showed IgA deficiency.
The final diagnoses of the patients with negative
serum EmA and normal intestinal histology were:
multiple food intolerance (three cases), Crohn’s disease
(two cases), sideropenic anaemia (three cases), major
recurrent aphtous stomatitis (3 cases), liver cirrhosis
(two cases), duodenal ulcer (one case).
The results of the IgA EmA and anti-tTG assayed on
the duodenal and oral mucosa culture were identical
and remained unchanged when the 31-43 peptide was
added to the culture medium. A cross-tabulation of
the EmA assay results on the culture medium of the
oral and duodenal biopsies obtained in paediatric and
adult patients, according to the final diagnoses, is
shown in Table 1. EmA assayed on the duodenal
mucosa culture medium gave results completely con-
cordant with the final diagnoses, as they were positive
in all patients with CD and negative in all patients not
suffering from CD. EmA assayed on the oral mucosa
culture medium was positive in 15 of the 28 patients
with CD (53.6%).
Also anti-tTG antibodies assayed on the duodenal
mucosa culture medium were positive in all patients
with CD and negative in all patients not suffering from
CD. Anti-tTG antibodies assayed on the oral mucosa
culture medium were positive in 16 of the 28 patients
with CD (57%) (Figure 1).
Table 2 shows the sensitivity, specificity and diag-
nostic accuracy of the EmA and anti-tTG assays on
the duodenal or oral mucosa culture medium in CD
diagnosis. As shown in Table 3, CD clinical
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presentation did not influence the behaviour of the
EmA and anti-tTG assays in the oral mucosa culture
medium. The presence of oral mucosa lesions did not
influence the EmA and anti-tTG assays on the oral
biopsy culture medium either. In fact, we observed
recurrent aphtous stomatitis in four patients with CD
and in four adult controls (three with final diagnosis
of major aphtous stomatitis and one with Crohn’s dis-
ease); only one of the four patients with CD and none
of these four controls were positive for EmA and anti-
tTG antibodies.
Figure 2 shows the number of lamina propria
lymphocytes in the oral mucosa of patients with CD
and controls. A greater severity of inflammation of the
oral mucosa was observed in the patients with CD with
positive EmA or anti-tTG in the oral mucosa culture
medium (Table 4). In fact, the frequency of positive
assays was significantly higher in the patients with
severe inflammation: P < 0.01 (Fisher’s test).
DISCUSSION
Although nowadays there is general agreement that
CD must be considered a systemic disease and may
affect several extra-intestinal organs, the intestinal
mucosa examination is still considered the corner
stone of a definitive CD diagnosis.6, 7, 12, 21 However,
the small bowel biopsy is an invasive procedure which
many patients – especially if asymptomatic or suffer-
ing from only mild symptoms – find hard to accept. In
this respect, a study of the potential diagnostic use of
the oral mucosa could be of great interest. In fact, the
oral mucosa is very often damaged in CD22 and previ-
ous studies in patients with CD on gluten-free diet
showed that both the oral supramucosal application
and submucosal injection of gliadin powder or gliadin
peptides induced significant immunological
changes.13, 14
As previous studies have demonstrated that EmA
and anti-tTG assays on duodenal mucosa culture med-
ium have an excellent diagnostic accuracy in CD diag-
nosis,16, 17, 23 we aimed to evaluate the ability of the
oral mucosa in patients with CD to produce EmA and
anti-tTG in a culture system, comparing results with
those obtained on duodenal mucosa culture.
Our results showed that the oral mucosa of patients
with a new CD diagnosis, still on a gluten-containing
Table 1. Cross-tabulation of the antiendomysial (EmA) assay results on the culture medium of the duodenal and oral biop-
sies, in adult and pediatric subjects, according to the final diagnoses
EmA assay on duodenal mucosa culture medium EmA assay on oral mucosa culture medium
Celiac disease (CD)
diagnosis (n)
Non-CD
diagnosis (n) Total no.
CD diagnosis
(n)
Non-CD
diagnosis (n) Total no.
Adults
Positive test 15 0 15 9 0 9
Negative test 0 14 14 6 14 20
Total 15 14 29 15 14 29
Children
Positive test 13 0 13 6 0 6
Negative test 0 0 0 7 0 7
Total 13 0 13 13 0 13
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Figure 1. Individual values of antitransglutaminase anti-
bodies assayed in the oral mucosa culture medium, in 28
celiac patients and in 14 patients not suffering from celiac
disease. Values are expressed as optical density (OD).
Dotted line indicates the upper normal limit.
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diet, was able to produce EmA and anti-tTG in the
culture medium, with or without in vitro gliadin sti-
mulation. In fact, EmA and anti-tTG assays were posit-
ive in 15 and 16 out of 28 patients with CD
respectively. This result is in keeping with the theory
that the mouth is part of the gut-associated lymphoid
tissue (GALT) system24 and, although its epithelium is
very different from that of the gut, the dissemination
of the immune effector cells involves the oral mucosa
and can determine a gliadin-induced response in
patients with CD.
However, in general, the sensitivity of CD-specific
antibodies assay in the oral mucosa culture medium
was low, with EmA assay more sensitive in adults
(60%) than in children (46%). One child negative for
EmA assay on oral culture medium resulted to be posi-
tive for anti-tTG assay. The sensitivity of the assays
was not influenced by clinical presentation as it did
Table 2. Sensitivity, specificity
and diagnostic accuracy in
celiac disease (CD) diagnosis
of the antibodies assays on the
culture medium of the duode-
nal and oral mucosa biopsies.
The study groups included 15
adult patients with CD, 13
pediatric patients with CD and
14 adult controls
Sensitivity Specificity Diagnostic accuracy
Antiendomysial (EmA) assay in duodenal mucosa culture medium
Adults 100% 100% 100%
Children 100% Not evaluated Not evaluated
Total 100% – –
EmA assay in oral mucosa culture medium
Adults 60% 100% 79%
Children 46% Not evaluated Not evaluated
Total 53.6% – –
Antitransglutaminase (anti-tTG) assay in duodenal mucosa culture medium
Adults 100% 100% 100%
Children 100% Not evaluated Not evaluated
Total 100% – –
Anti-tTG assay in oral mucosa culture medium
Adults 60% 100% 79%
Children 54% Not evaluated Not evaluated
Total 57% – –
Table 3. Results of antiend-
omysial (EmA) and anti-
transglutaminase (anti-tTG)
assays in the oral mucosa cul-
ture medium according to the
different clinical presentations
in 28 celiac disease (CD)
patients
Typical CD
presentation
Atypical CD
presentation Silent CD
Number of EmA positive assays 7 cases 7 cases 1 case
Number of EmA negative assays 7 cases 5 cases 1 case
Number of anti-tTG positive assays 8 cases 7 cases 1 case
Number of anti-tTG negative assays 6 cases 5 cases 1 case
The CD clinical presentation was considered typical when there was malabsorption syn-
drome, atypical in the absence of intestinal symptoms, and silent in the absence of
symptoms.
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Figure 2. Number of the lamina propria lymphocytes in
the oral mucosa in 15 celiac disease (CD) patients with
positive antiendomysial (EmA) assay in the oral mucosa
culture medium (GROUP 1), in 13 patients with CD with
negative EmA assay in the oral mucosa culture medium
(GROUP 2) and in 14 patients without CD (GROUP 3).
Lines indicate the mean values.
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not differ between patients with typical, atypical or
silent disease. Furthermore, the presence of ‘macro-
scopic’ oral manifestations was not relevant as four
patients with CD were suffering from recurrent aph-
tous stomatitis at the moment of the study but only
one of these was positive for both EmA and anti-tTG
assays on oral mucosa culture medium. There was a
positive correlation between severity of the lympho-
cytes infiltration in the lamina propria of the oral
mucosa and EmA or anti-tTG positivity in the culture
medium. This aspect is similar to the well-known
observation that there is a positive correlation between
the severity of intestinal histology and the presence of
serum EmA in CD.17, 25
Antiendomysial and anti-tTG assays on the oral
mucosa culture medium showed a specificity of 100%,
as we did not observe false positive results. It must be
underlined that even the presence of recurrent aphtous
stomatitis – present in four controls – did not deter-
mine false positive EmA ⁄ anti-tTG results. Obviously, as
we included few control patients, further studies are
needed to confirm the absolute specificity of the EmA
or anti-tTG assays on the oral mucosa culture medium.
A previous study of the oral mucosa histology of
untreated patients with CD did not show any signifi-
cant histological alterations, which could help diagno-
sis and the oral gluten challenge performed on
patients with CD on gluten-free diet showed a sensitiv-
ity of 73% and specificity of 80%.26 However, the
immuno-histochemical methods used in previous stud-
ies13, 14 were more cumbersome and time-consuming
than the simple antibodies assay in the culture med-
ium. Furthermore, the evidence that anti-tTG antibod-
ies can be effectively assayed in the oral mucosa
culture medium opens the way to an easy ELISA.
As regards antibodies assay on duodenal mucosa
culture medium, our results are in keeping with all
previous reports, which have underlined the excellent
diagnostic value of this assay.13, 14 The intestine is the
main site of EmA production and both EmA or anti-
tTG can also be assayed in the whole gut lavage
fluid27 or in the duodenal mucosa by immuno-histo-
chemistry,28, 29 giving relevant diagnostic help in cases
of seronegative patients with CD.
In conclusion, this study demonstrated for the first
time that the oral mucosa contributes to EmA and
anti-tTG production in untreated patients with CD. As
the search for easier diagnostic methods than the small
intestine biopsy procedure is important, the antibodies
assay on oral mucosa culture medium merits further
evaluation.
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Table 4. Results of antiend-
omysial (EmA) and anti-
transglutaminase (anti-tTG)
assays in the oral mucosa cul-
ture medium according to the
severity of the lymphocytes
infiltration in the lamina pro-
pria of the oral mucosa
Mild
inflammation
Severe
inflammation
Number of EmA positive assays 7 cases 8 cases
Number of EmA negative assays 10 cases 3 cases
Number of anti-tTG positive assays 7 cases 9 cases
Number of anti-tTG negative assays 10 cases 2 cases
Lamina propria lymphocytes infiltration was graded as mild when £10 lymphocytes · 5
HPF (magnification 40·) were counted, and severe when there were >10 lympho-
cytes · 5 HPF.
The frequency of EmA positive assays was significantly higher in the patients with
severe inflammation: P < .01 (Fisher’s test).
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